Waldron Private Wealth’s TScan Therapeutics TCRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $14.5K | Hold |
10,000
| – | – | ﹤0.01% | 298 |
|
|
2025
Q1 | $13.8K | Hold |
10,000
| – | – | ﹤0.01% | 292 |
|
|
2024
Q4 | $30.4K | Hold |
10,000
| – | – | ﹤0.01% | 416 |
|
|
2024
Q3 | $49.8K | Hold |
10,000
| – | – | ﹤0.01% | 439 |
|
|
2024
Q2 | $58.5K | Hold |
10,000
| – | – | ﹤0.01% | 407 |
|
|
2024
Q1 | $79.4K | Hold |
10,000
| – | – | ﹤0.01% | 414 |
|
|
2023
Q4 | $58.3K | Hold |
10,000
| – | – | ﹤0.01% | 404 |
|
|
2023
Q3 | $25.6K | Hold |
10,000
| – | – | ﹤0.01% | 371 |
|
|
2023
Q2 | $25K | Hold |
10,000
| – | – | ﹤0.01% | 370 |
|
|
2023
Q1 | $21K | Buy |
+10,000
| New | +$21K | ﹤0.01% | 416 |
|